Tax Considerations for the Life Cycle of Emerging Bio Companies

Participants of the free live webinar will be eligible for 1 CPE credit. Register Insights from 2023 reporting and a forecast into HCP engagement strategies and compliance trends in 2024 Life sciences organizations face many complexities and challenges associated with spend transparency regulations and reporting obligations, including navigating the intricacies of timing to complete reporting, establishing efficient and accurate reporting methodologies, and anticipating forthcoming developments. Furthermore, managing these complexities while extracting tangible value in terms of data analytics from a…

Participants of the free live webinar will be eligible for 1 CPE credit. Register On September 13, 2022, the U.S. Food and Drug Administration (FDA) issued draft guidance providing recommendations on Computer Software Assurance (CSA) for computers and automated data processing systems used as part of life sciences organizations’ production or quality systems. The guidance would allow for—and even encourage—the industry to adopt a simpler assurance approach that emphasizes critical thinking and assurance needs as opposed to testing and documentation.…